D F Sahm
Overview
Explore the profile of D F Sahm including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
2248
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Jones M, Goguen J, Critchley I, Draghi D, Karlowsky J, Sahm D, et al.
Clin Microbiol Infect
. 2003 Nov;
9(9):984-6.
PMID: 14616693
Bacillus anthracis is a bacterial species that could be used in a bioterrorist attack. We tested a collection of isolates with a range of relevant antimicrobial compounds. All isolates tested...
12.
Jones M, Blosser-Middleton R, Critchley I, Karlowsky J, Thornsberry C, Sahm D
Clin Microbiol Infect
. 2003 Aug;
9(7):590-9.
PMID: 12925097
Objective: To assess the current (2001) activity of respiratory fluoroquinolones and comparator agents against respiratory pathogens isolated in European countries. Methods: During 2000-2001, we prospectively collected 1995 isolates of Haemophilus...
13.
Blosser-Middleton R, Sahm D, Thornsberry C, Jones M, Hogan P, Critchley I, et al.
Clin Microbiol Infect
. 2003 Jul;
9(5):431-6.
PMID: 12848759
In 2000-2001, 840 clinical isolates of Haemophilus influenzae were collected from laboratories in France, Germany, Italy and Spain (210 isolates/country). Beta-Lactamase production among the isolates varied considerably by country, ranging...
14.
Critchley I, Jones M, Heinze P, Hubbard D, Engler H, Evangelista A, et al.
Clin Microbiol Infect
. 2002 Jun;
8(4):214-21.
PMID: 12047413
Objective: To assess the activities of levofloxacin and the comparator agents erythromycin, clarithromycin, azithromycin and doxycycline against atypical respiratory pathogens. Methods: One hundred and forty-six Legionella pneumophila, 41 Mycoplasma pneumoniae...
15.
Critchley I, Blosser-Middleton R, Jones M, Yamakita J, Aswapokee N, Chayakul P, et al.
J Chemother
. 2002 May;
14(2):147-54.
PMID: 12017369
A multi-center surveillance study was conducted in Thailand during 1999-2000 to determine antimicrobial susceptibilities among the respiratory pathogens Streptococcus pneumoniae (n = 206), Haemophilus influenzae (n = 305), and Moraxella...
16.
Karlowsky J, Jones M, Mayfield D, Thornsberry C, Sahm D
Int J Antimicrob Agents
. 2002 May;
19(5):413-26.
PMID: 12007850
Ceftriaxone was introduced into clinical practice in the USA in 1985 and was the first extended-spectrum (third-generation) cephalosporin approved for once-daily treatment of patients with Gram-positive or Gram-negative infections. Review...
17.
Critchley I, Blosser R, Karlowsky J, Yamakita J, Barth A, Sader H, et al.
Braz J Infect Dis
. 2002 May;
5(6):294-304.
PMID: 11980591
The in vitro antimicrobial susceptibility of the respiratory pathogens Streptococcus Pneumoniae, Hemophilus influenzae, and Moraxella catarrhalis to commonly tested and prescribed agents was investigated during 1999-2000 and compared with results...
18.
Jones M, Gesu G, Ortisi G, Sahm D, Critchley I, Goglio A
Clin Microbiol Infect
. 2002 Apr;
8(2):101-11.
PMID: 11952723
Objective: To assess the ability of 59 clinical microbiology laboratories distributed throughout Italy to correctly identify and detect reduced susceptibility to glycopeptides in staphylococci and VanA-, VanB- or VanC-mediated glycopeptide...
19.
Baden L, Critchley I, Sahm D, So W, Gedde M, Porter S, et al.
J Clin Microbiol
. 2002 Mar;
40(4):1160-3.
PMID: 11923325
We characterized baseline and repopulating stool isolates recovered during a phase II trial of ramoplanin for the treatment of patients with stool carriage of vancomycin-resistant enterococci (VRE). Repopulation with a...
20.
Thornsberry C, Karlowsky J, Kelly L, Draghi D, Critchley I, Jones M, et al.
Chemotherapy
. 2001 Sep;
47(5):332-43.
PMID: 11561135
Background: In vitro studies of cefditoren activity have focused primarily on Streptococcus pneumoniae and other bacterial species isolated from patients with respiratory infections, but relatively few reports have been published...